Daniel Hendler
- Hepatology top 1%
- Oncology top 0.5%
- Cancer Treatment and Pharmacology 5
- Cancer Immunotherapy and Biomarkers 3
- Neutropenia and Cancer Infections 3
- Cancer Risks and Factors 2
- Colorectal Cancer Treatments and Studies 2
- HER2/EGFR in Cancer Research 2
- Dermatology top 2%
-
- Breast Cancer Treatment Studies 4
-
- Nonmelanoma Skin Cancer Studies 2
Daniel Hendler
17 papers receiving 3.1k citations
Hit Papers
Peers
Comparison fields: 5 of 91
- Hepatology 899
- Oncology 2.7k
- Pulmonary and Respiratory Medicine 824
- Pathology and Forensic Medicine 407
- Dermatology 183
Countries citing papers authored by Daniel Hendler
This map shows the geographic impact of Daniel Hendler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Hendler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Hendler more than expected).
Fields of papers citing papers by Daniel Hendler
This network shows the impact of papers produced by Daniel Hendler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Hendler. The network helps show where Daniel Hendler may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel Hendler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 11 | |
| 3 | 2023 | 10 | |
| 4 | 2021 | 2 | |
| 5 | 2020 | 2 | |
| 6 | 2020 | 5 | |
| 7 | 2020 | 1 | |
| 8 | 2019 | 4 | |
| 9 | 2017 | 24 | |
| 10 | 2017 | 0 | |
| 11 | 2016 | 4 | |
| 12 | 2016 | 29 | |
| 13 | 2016 | 6 | |
| 14 | 2016 | 5 | |
| 15 | 2014 | 7 | |
| 16 | 2012 | 1 | |
| 17 | 2011 | 17 | |
| 18 | 2010 | 1 | |
| 19 | Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancerbreakdown → | 2000 | 3040 |
About Daniel Hendler
Daniel Hendler is a scholar working on Oncology, Cancer Research and Dermatology, having authored 19 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Breast Cancer Treatment Studies (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Neutropenia and Cancer Infections (3 papers), Cancer Risks and Factors (2 papers), Colorectal Cancer Treatments and Studies (2 papers), HER2/EGFR in Cancer Research (2 papers) and Nonmelanoma Skin Cancer Studies (2 papers). The work is most often cited by research in Hepatology (899 citations), Oncology (2.7k citations) and Pulmonary and Respiratory Medicine (824 citations). Daniel Hendler has collaborated with scholars based in Israel, France and Italy. Frequent co-authors include Arié Figer, N Le Bail, D. Papamichael, M. Homerin, C. Wilson, Christophe Louvet, Filippo de Braud, H. Cortés-Funes, Michel Seymour and Aimery de Gramont. Their work appears in journals such as Journal of Clinical Oncology, Breast Cancer Research and Treatment, Cancer Research, Journal of Oncology and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.